PRGO logo

Perrigo (PRGO)

Profile

Full Name

Perrigo Company plc

Ticker Symbol

PRGO

Exchange

NYSE

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

Ireland

IPO

December 17, 1991

Indexes

Not included

Website

http://www.perrigo.com

Employees

8379

Key Details

Price

$25.14(+0.32%)

Market cap

$3.43B(Mid cap)

Last Dividend

$0.29

TTM Dividend yield

4.45%

Annual revenue

$4.37B(-6.06% YoY)

Annual EPS

-$1.25(-1288.89% YoY)

PE ratio

-

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$25.14
PRGO price is $25.14

30-Day Relative Volume

0.71
PRGO 30-day relative volume is 0.71

Price Performance

Price Most recent change

+0.32%
PRGO price was up +0.32% on Apr 16, 2025

Price YTD change

-2.22%
PRGO price is down -2.22% since January 1st

Price 1-year change

-16.31%
PRGO price is down -16.31% year-on-year

Price 3-year change

-30.13%
PRGO price is down -30.13% over the past 3 years

Price Range

Price All-time high

$215.73
PRGO price is currently -88.35% below its historical high of $215.73

Price 3-year low

$23.14
PRGO price is currently +8.64% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$3.43B
PRGO market capitalization is $3.43 billion

Market cap 3-year change

-29.16%
PRGO market capitalization is down -29.16% over the past 3 years

Market cap All-time high

$29.03B
PRGO market capitalization is currently -88.18% below its historical high of $29.03 billion

Market cap sector rank

87.75%
PRGO market capitalization is higher than 87.75% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.12%
PRGO shares outstanding is up +0.12% year-on-year

Shares Outstanding 3-Year Change

+1.38%
PRGO shares outstanding is up +1.38% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.55
PRGO beta is 0.55

200-day SMA

$26.55
PRGO price is currently -5.29% below its 200-day simple moving average

50-day SMA

$26.44
PRGO price is currently -4.93% below its 50-day simple moving average

RSI

41.71
PRGO 14-day relative strength index is 41.71

Volume

0.71
PRGO 30-day relative volume is 0.71

ATR

$0.95
PRGO average true range is $0.95

10-day Historical Volatility

55.15%
PRGO 10-day historical volatility is 55.15%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.29
PRGO last dividend was $0.29 per share, with an ex-dividend date of March 7, 2025

Next Dividend

-
PRGO next dividend has not yet been announced

Dividend per share

Dividend per share

$1.10
PRGO annual dividend per share is $1.10

Dividend per share Sector Rank

47.67%
PRGO annual dividend per share is higher than 47.67% of companies in Healthcare sector

Dividend per share 1-Year Change

+1.1%
PRGO annual dividend per share is up +1.1% year-on-year

Dividend per share 3-Year Change

+15%
PRGO annual dividend per share is up +15% over the past 3 years

Dividend yield

Dividend yield

4.39%
PRGO annual dividend yield is 4.39%

Dividend yield Sector Rank

80%
PRGO annual dividend yield is higher than 80% of companies in Healthcare sector

Other

Payout ratio

-88.77%
PRGO annual payout ratio is -88.77%

Dividends paid

$152.50M
PRGO annual dividends paid is $152.50 million

Free cash flow

$244.60M
PRGO annual free cash flow is $244.60 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$4.37B
PRGO annual revenue is $4.37 billion

Revenue Analysts estimate

$4.44B
PRGO annual revenue is currently -1.42% lower than the consensus analysts' forecast

Revenue 1-year change

-6.06%
PRGO annual revenue is down -6.06% year-on-year

Revenue Sector rank

91.38%
PRGO annual revenue is higher than 91.38% of companies in Healthcare sector

EPS

EPS

-$1.25
PRGO annual earnings per share is -$1.25

EPS Analysts estimate

$2.99
PRGO annual earnings per share is currently -141.86% lower than the consensus analysts' forecast

EPS 1-year change

-1288.89%
PRGO annual earnings per share is down -1288.89% year-on-year

EPS Sector rank

50.83%
PRGO annual earnings per share is higher than 50.83% of companies in Healthcare sector

Profit

Gross profit

$1.54B
PRGO annual gross profit is $1.54 billion

Gross margin

35.27%
PRGO annual gross profit margin is 35.27%

Operating profit

$311.90M
PRGO annual operating income is $311.90 million

Operating margin

7.13%
PRGO annual operating profit margin is 7.13%

Net income

-$171.80M
PRGO annual net profit is -$171.80 million

Net margin

-3.93%
PRGO annual net profit margin is -3.93%

Expenses

Total expenses

$4.06B
PRGO annual total expenses is $4.06 billion

Operating expenses

$1.23B
PRGO annual total operating expenses is $1.23 billion

Cost of goods sold

$2.83B
PRGO annual cost of goods sold is $2.83 billion

Selling, general & administrative expenses

$1.11B
PRGO annual SGA is $1.11 billion

Depreciation and amortization

$325.90M
PRGO annual depreciation & amortization is $325.90 million

Interest expense

$187.80M
PRGO annual interest expense is $187.80 million

Income tax

$80.00M
PRGO annual income tax is $80.00 million

EBIT & EBITDA

EBIT

$107.10M
PRGO annual earnings before interest & taxes is $107.10 million

EBITDA

$433.00M
PRGO annual EBITDA is $433.00 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$9.65B
PRGO annual total assets is $9.65 billion

Non current assets

$7.17B
PRGO annual long term assets is $7.17 billion

Current assets

$2.48B
PRGO annual total current assets is $2.48 billion

Cash and cash equivalents

$558.80M
PRGO annual cash & cash equivalents is $558.80 million

Accounts receivable

$642.30M
PRGO annual accounts receivable is $642.30 million

Inventory

$1.08B
PRGO annual inventory is $1.08 billion

Liabilities

Total liabilities

$5.33B
PRGO annual total liabilities is $5.33 billion

Long term liabilities

$4.28B
PRGO annual total long term liabilities is $4.28 billion

Current liabilities

$1.04B
PRGO annual total current liabilities is $1.04 billion

Accounts payable

$495.20M
PRGO annual accounts payable is $495.20 million

Debt

Total debt

$3.62B
PRGO annual total debt is $3.62 billion

Total debt 1-year change

-11.18%
PRGO annual total debt is down -11.18% year-on-year

Long term debt

$3.58B
PRGO annual long term debt is $3.58 billion

Short term debt

$36.40M
PRGO annual short term debt is $36.40 million

Equity & Capital

Shareholders equity

$4.32B
PRGO annual stockholders equity is $4.32 billion

Book value

$4.32B
PRGO annual book value is $4.32 billion

Retained earnings

-$2.25B
PRGO annual retained earnings is -$2.25 billion

Working capital

$1.44B
PRGO annual working capital is $1.44 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$362.90M
PRGO annual cash flow from operations is $362.90 million

Cash from operations 1-year change

-10.51%
PRGO annual cash flow from operations is down -10.51% year-on-year

Cash from investing

$78.80M
PRGO annual cash flow from investing activities is $78.80 million

Cash from investing 1-year change

+201.68%
PRGO annual cash flow from investing activities is up +201.68% year-on-year

Cash from financing

-$611.00M
PRGO annual cash flow from financing activities is -$611.00 million

Cash from financing 1-year change

-226.39%
PRGO annual cash flow from financing activities is down -226.39% year-on-year

CAPEX

CAPEX

$118.30M
PRGO annual capital expenditures is $118.30 million

CAPEX 1-year change

+16.32%
PRGO annual capital expenditures is up +16.32% year-on-year

Free Cash Flow

Free cash flow

$244.60M
PRGO annual free cash flow is $244.60 million

Free cash flow 1-year change

-19.49%
PRGO annual free cash flow is down -19.49% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

35.27%
PRGO annual gross profit margin is 35.27%

Operating margin

7.13%
PRGO annual operating profit margin is 7.13%

Net margin

-3.93%
PRGO annual net profit margin is -3.93%

ROA & ROE

ROA

-1.68%
PRGO annual return on assets is -1.68%

ROE

-3.78%
PRGO annual return on equity is -3.78%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
PRGO price to earnings ratio value is unknown

PE ratio Sector rank

-
PRGO price to earnings ratio is unknown

PB Ratio

PB ratio

0.79
PRGO price to book ratio is 0.79

PB ratio Sector rank

40.03%
PRGO price to book ratio is higher than 40.03% of companies in Healthcare sector

PS Ratio

PS ratio

0.78
PRGO price to sales ratio is 0.78

PS ratio Sector rank

23.97%
PRGO price to sales ratio is higher than 23.97% of companies in Healthcare sector

Enterprise value

Enterprise value

$6.49B
PRGO enterprise value is $6.49 billion

Enterprise value Sector rank

89.84%
PRGO enterprise value is higher than 89.84% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

14.99
PRGO EV/EBITDA is 14.99

EV/EBITDA Sector rank

88.09%
PRGO EV/EBITDA is higher than 88.09% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.38
PRGO annual current ratio is 2.38

Quick ratio

1.34
PRGO annual quick ratio is 1.34

Leverage

Debt to equity

0.84
PRGO annual debt to equity ratio is 0.84

Interest coverage ratio

0.57
PRGO annual interest coverage ratio is 0.57

Risk & Stability

Piotroski F-Score

4
PRGO piotroski f-score is 4

Altman Z-Score

0.73
PRGO altman z-score is 0.73

Analyst ratings

Recent major analysts updates

Jan 6, 25 Piper Sandler
Neutral
Sep 30, 24 Canaccord Genuity
Buy
Sep 23, 24 Jefferies
Hold
Jul 11, 24 Piper Sandler
Overweight
Jun 13, 24 Piper Sandler
Overweight
Apr 12, 24 Canaccord Genuity
Buy
Apr 8, 24 Piper Sandler
Overweight
Feb 28, 24 JP Morgan
Overweight
Nov 17, 23 Piper Sandler
Overweight
Aug 9, 23 JP Morgan
Overweight

Institutional Ownership

Similar stocks

ICUI logo
ICU Medical (ICUI)
ACLX logo
Arcellx (ACLX)
CRSP logo
CRISPR Therapeutics AG (CRSP)
RARE logo
Ultragenyx Pharmaceutical (RARE)
SLNO logo
Soleno Therapeutics (SLNO)
PTCT logo
PTC Therapeutics (PTCT)
IRTC logo
iRhythm Technologies (IRTC)
ZLAB logo
Zai Lab Limited (ZLAB)
ALHC logo
Alignment Healthcare (ALHC)
  • What is the ticker symbol for Perrigo?
  • Does Perrigo pay dividends?
  • What sector is Perrigo in?
  • What industry is Perrigo in?
  • What country is Perrigo based in?
  • When did Perrigo go public?
  • Is Perrigo in the S&P 500?
  • Is Perrigo in the NASDAQ 100?
  • Is Perrigo in the Dow Jones?
  • When was Perrigo's last earnings report?
  • When does Perrigo report earnings?
  • Should I buy Perrigo stock now?

What is the ticker symbol for Perrigo?

The ticker symbol for Perrigo is NYSE:PRGO

Does Perrigo pay dividends?

Yes, Perrigo pays dividends. The last payment was $0.29, with an ex-dividend date on March 7, 2025

What sector is Perrigo in?

Perrigo is in the Healthcare sector

What industry is Perrigo in?

Perrigo is in the Drug Manufacturers - Specialty & Generic industry

What country is Perrigo based in?

Perrigo is headquartered in Ireland

When did Perrigo go public?

Perrigo's initial public offering (IPO) was on December 17, 1991

Is Perrigo in the S&P 500?

No, Perrigo is not included in the S&P 500 index

Is Perrigo in the NASDAQ 100?

No, Perrigo is not included in the NASDAQ 100 index

Is Perrigo in the Dow Jones?

No, Perrigo is not included in the Dow Jones index

When was Perrigo's last earnings report?

Perrigo's most recent earnings report was on Feb 27, 2025

When does Perrigo report earnings?

The next expected earnings date for Perrigo is May 7, 2025

Should I buy Perrigo stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page